<?xml version="1.0" encoding="UTF-8"?>
<p>Cytokine storm and inflammation induced by the uncontrolled immunologic response to the virus underlies the fatal pneumonia that can follow infection with human coronaviruses.
 <xref rid="mja250577-bib-0011" ref-type="ref">11</xref>, 
 <xref rid="mja250577-bib-0012" ref-type="ref">12</xref> Inhibition of inflammation improves outcomes in animals infected with SARS and MERS viruses.
 <xref rid="mja250577-bib-0013" ref-type="ref">13</xref>, 
 <xref rid="mja250577-bib-0014" ref-type="ref">14</xref> Corticosteroids are typically used to treat severe acute respiratory infections of viral aetiology because of their anti‚Äêinflammatory effect.
 <xref rid="mja250577-bib-0015" ref-type="ref">15</xref> However, it was reported that corticosteroids did not improve outcomes during the SARS and MERS outbreaks, but delayed viral clearance and increased rates of secondary infections.
 <xref rid="mja250577-bib-0009" ref-type="ref">9</xref>, 
 <xref rid="mja250577-bib-0016" ref-type="ref">16</xref>, 
 <xref rid="mja250577-bib-0017" ref-type="ref">17</xref> Most patients in the relevant studies were critically ill with ARDS, and may have passed the point where adverse outcomes could be modified by steroid therapy.
</p>
